Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinosarcoma

medroxyprogesterone acetate has been researched along with Carcinosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiwara, H; Kosuge, S; Ohwada, M; Sato, I; Shibahara, H; Suzuki, M; Takamizawa, S; Usui, R	1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Carcinosarcoma

Article	Year
Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma. American journal of reproductive immunology (New York, N.Y. : 1989), 2002, Volume: 47, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Uterine Neoplasms	2002

Article

Year

Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.

American journal of reproductive immunology (New York, N.Y. : 1989), 2002, Volume: 47, Issue:3

Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Uterine Neoplasms

2002